Basit öğe kaydını göster

dc.contributor.authorBener, Abdulbari
dc.contributor.authorKeskin, Fatma Ela
dc.contributor.authorKurtuluş, Eda Merve
dc.contributor.authorGüzel, Mustafa
dc.contributor.authorÇekirdekçi, Elif İjlal
dc.contributor.authorKadıoğlu, Pınar
dc.contributor.authorKonukoğlu, Dildar
dc.contributor.authorÖztürk, Mustafa
dc.date.accessioned10.07.201910:49:13
dc.date.accessioned2019-07-10T19:51:50Z
dc.date.available10.07.201910:49:13
dc.date.available2019-07-10T19:51:50Z
dc.date.issued2017en_US
dc.identifier.citationBener, A., Keskin, F. E., Kurtuluş, E. M., Güzel, M., Çekirdekçi, E. İ., Kadıoğlu, P. ... Öztürk, M. (2017). Essential parameters and risk factors of the patients for diabetes care and treatment. Diabetes & Metabolic Syndrome-Clinical Research & Reviews, 11(Supplement: 1), S315-S320. https://dx.doi.org/10.1016/j.dsx.2017.03.008en_US
dc.identifier.issn1871-4021
dc.identifier.issn1878-0334
dc.identifier.urihttps://dx.doi.org/10.1016/j.dsx.2017.03.008
dc.identifier.urihttps://hdl.handle.net/20.500.12511/2292
dc.descriptionWOS: 000419836500052en_US
dc.descriptionPubMed ID: 28285988en_US
dc.description.abstractAim: The aim was to explore the association between Type 2 Diabetes Mellitus [T2DM] treatment satisfactions of patients regarding their socio-economic, life-style, history medication and clinical outcome in a Turkish population Subject and methods: A cross-sectional study conducted from February 2016 to September 2016. Of the total 1500 diabetic patients approached, 1094 (72.9%) gave their consent. Data analysis included, sociodemographic, serum lipid profiles (LDL, HDL), calcium, uric acid, blood pressure and glycated hemoglobin (HbA1c) at baseline and after six months. The Diabetes Treatment Satisfaction Questionnaire (DTSQ) tools were used to measure the patient satisfaction. Results: The mean and standard deviation of age among gender, there were significant differences between males (51.81 +/- 14.40) and females (49.76 +/- 13.99) (p = 0.024). There were statistically significant differences between males and females regarding place of living (city 76% vs town 26%) p < 0.001) and consanguinity (p = 0.040). Almost of the patients with diabetes were overweight (males 44.5% vs females 41.8%) while more than a quarter (31.2%) males were obese. Among patients with diabetes, significantly larger proportion were treated for DM with insulin (females 28.8% vs males 22.5%) and 'insulin & oral anti diabetic drugs' (females 21.6% vs males 18.4%%; p < 0.001) in comparison. Reported average sleeping haours was significantly more among males (6.5 +/- 1.1 vs. 6.1 +/- 1.2; p < 0.001) than females. Males and females reported significantly greater improvements in mean values of blood glucose (-2.07 p < 0.001; vs.-2.36; p = 0.007), HbA1c (-1.72 p < 0.001; vs.-1.47 p = 0.038), potassium (+0.98 p < 0.001; vs. +0.93 p< 0.005); albumin (-3.38 p < 0.001; vs.-3.60; p < 0.001); billirubin (-0.69 p = 0.049; vs.-0.98; p < 0.001); uric acid (+11.9 p = 0.017; vs. +14.3; p < 0.001); systolic blood pressure (-3.86 p < 0.001; vs.-3.2 p < 0.001) and diastolic blood pressure (-3.17 p < 0.001; vs.-3.2 p < 0.001) in comparison to 6 months before. Multivariate stepwise regression analysis showed that the satisfaction DTSQ scores for HbAlc (p < 0.001), h of sleep (p < 0.001), neuropathy (p = 0.007), diabetic education (p = 0.014), SBP (mmHg) (p = 0.021) DBP (mmHg) (p = 0.028) were identified as significantly associated with higher treatment satisfaction. Conclusion: The study confirms a positive correlation between diabetes patient's satisfaction with care and treatment. Females DM patients compared to males had a better satisfaction score with current treatment, unacceptably low blood glucose level, flexibility in treatment and understanding of DM.en_US
dc.description.sponsorshipCerrahpasa Faculty of Medicine and Medipol International School of Medicine, Istanbul Medipol Universityen_US
dc.description.sponsorshipWe are grateful to the developer of the DTSQ Professor Clare Bradley for granting us permission to use the instrument in our study. The authors would like to thank the Cerrahpasa Faculty of Medicine and Medipol International School of Medicine, Istanbul Medipol University for their support and ethical approval.en_US
dc.language.isoengen_US
dc.publisherElsevier Ltden_US
dc.rightsinfo:eu-repo/semantics/embargoedAccessen_US
dc.subjectDiabetes Careen_US
dc.subjectLife-Styleen_US
dc.subjectPatient Satisfactionen_US
dc.subjectDTSQen_US
dc.subjectTreatment Adherenceen_US
dc.subjectHealth Statusen_US
dc.titleEssential parameters and risk factors of the patients for diabetes care and treatmenten_US
dc.typearticleen_US
dc.relation.ispartofDiabetes & Metabolic Syndrome-Clinical Research & Reviewsen_US
dc.departmentİstanbul Medipol Üniversitesi, Uluslararası Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Tıbbi Farmakoloji Ana Bilim Dalıen_US
dc.authorid0000-0002-1423-0435en_US
dc.authorid0000-0002-7902-5803en_US
dc.identifier.volume11en_US
dc.identifier.issueSupplement: 1en_US
dc.identifier.startpageS315en_US
dc.identifier.endpageS320en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.doi10.1016/j.dsx.2017.03.008en_US
dc.identifier.scopusqualityQ2en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster